Besides a difference in EPO, RDW and MCV were higher in bone marrow disease group, which was consistent with previous reports27,28, though RDW was not significantly different in the subgroup analysis, indicating that it may not be a reliable marker for detecting bone marrow disease in some cases. This evidence concerns the gene EPO and bone marrow disorder.